Sunday, July 15, 2018 3:44:48 PM
**Dr. Tony Manning - April 2016:
http://www.momentapharma.com/docs/presentation_PEGs-2016-Manning_biocharacterization-of-autoimmune-disease.pdf
****OOPS! Read page one carefully.
**Dr. Elma Kurtagic - May 2017:
http://www.momentapharma.com/docs/presentation_PEGs-2017_Kurtagic_Scleroderna-and-Fibrotic-Disorders.pdf
In a nut shell - We are applying precision medicine tools to develop the right drug for the right patient
LUV this -
Momenta has developed a powerful engine—not unlike other companies, but differentiated by our core know-how of deconvoluting complexity—resulting in unique, actionable insights into new healthcare solutions.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM